Source Post
Why Is Viking Therapeutics Stock Crashing and is it a Buying Opportunity? | VKTX Stock, LLY, NVO
Aug 26, 2025
Viking Therapeutics' stock price crashed after releasing results for its oral weight loss pill, VK2735. While the pill demonstrated significant weight loss, the higher-than-expected side effects, primarily nausea and vomiting, led to a higher discontinuation rate compared to placebo. This, combined with the effectiveness, caused the stock to fall, despite competition from Eli Lilly and Novo Nordisk.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.